Practice of the New Integrated Molecular Diagnostics in Gliomas: Experiences and New Findings in a Single Chinese Center
Conclusion: We detected the newly recommended markers in a large cohort of Chinese glioma patients. Our data demonstrated a relatively lower frequency of IDH mutations and a higher prevalence of triple-negative glioma in Chinese compared with American and European, indicating ethnic and geographical difference in some markers. In addition, the new molecular phenotype “IDH wildtype and 1p/19q codeletion” glioma deserved special focus. These findings suggest that further stratification of infiltrating gliomas is needed for different treatment strategy and precision medicine.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Wan-Ming Hu, Fang Wang, Shao-Yan Xi, Xiao Zhang, Jun-Peng Lai, Hui-Yu Wu, Li-Ling Liu, Ke Sai, Jing Zeng Tags: Research Paper Source Type: research
More News: Astrocytoma | Brain Tumor | Cancer | Cancer & Oncology | China Health | Fish | Glioma | Men